Join to View Full Profile
601 Lexington Ave 54th floorNew York, NY 10022
Phone+1 212-739-6400
Dr. Asmal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Massachusetts General Hospital/Brigham and Women's HospitalFellowship, Infectious Disease, 2006 - 2008
Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 2003 - 2006
Columbia University Vagelos College of Physicians and SurgeonsClass of 2003
Certifications & Licensure
MA State Medical License 2005 - 2019
Publications & Presentations
PubMed
- 32 citationsLovo-cel gene therapy for sickle cell disease: Treatment process evolution and outcomes in the initial groups of the HGB-206 study.Julie Kanter, Alexis A Thompson, Francis J Pierciey Jr, Matthew Hsieh, Naoya Uchida
American Journal of Hematology. 2023-01-01 - 140 citationsBiologic and Clinical Efficacy of LentiGlobin for Sickle Cell Disease.Julie Kanter, Mark C Walters, Lakshmanan Krishnamurti, Markus Y Mapara, Janet L Kwiatkowski
The New England Journal of Medicine. 2022-02-17 - 89 citationsBetibeglogene Autotemcel Gene Therapy for Non-β/βGenotype β-Thalassemia.Franco Locatelli, Alexis A Thompson, Janet L Kwiatkowski, John B Porter, Adrian J Thrasher
The New England Journal of Medicine. 2022-02-03
Press Mentions
HiFiBiO Therapeutics Submits IND Application for Fully Human SARS-CoV-2 Neutralizing Antibody for the Treatment of COVID-19 PatientsAugust 26th, 2020
Bluebird Bio Announces Topics for Gene Therapy Day, October Investor PresentationOctober 6th, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
